vTv Therapeutics (VTVT) Tops Q1 EPS by 165c
Tweet
Share
E-mailGet Alerts VTVT Hot Sheet
Join SI Premium – FREE
vTv Therapeutics (NASDAQ: VTVT) reported Q1 EPS of $1.65. Revenue for the quarter came in at $36.84 million.
For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
- Air Conditioning Company in South Florida, Peachy Keen Air Conditioning, Plumbing, Heating, Launches Safety Initiative
- Altrova Health Reports Third Quarter Fiscal 2026 Financial Results
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
